Report cover image

Patient-Derived Xenograft/PDX Model Market Outlook 2025: Industry Trends, Market Size, Share, and Growth Insights

Published Aug 01, 2025
Length 154 Pages
SKU # PCBS20327610

Description

The Patient-Derived Xenograft/PDX Model Market report by Precision Business Insights provides a comprehensive research approach combining primary and secondary research to ensure the highest possible accuracy in estimates and forecasts of the market size, share, growth, trends, key segments, competitive landscape, and major drivers and challenges. Our approach combines both top-down and bottom-up strategies to segment and estimate the quantitative aspects of the market.

Additionally, we incorporate data triangulation as a recurring theme in all our research reports, analyzing the market from three different perspectives. Our methodology places significant emphasis on minimizing deviation in order to produce the most reliable results.

The Patient-Derived Xenograft/PDX Model Market has witnessed significant growth in recent years and is expected to continue its upward trend in the coming years. The growing investment in Research and Development activities is a key driver of the market's growth. The research further provides global and regional estimates of the market, categorized by country and segment within each region. The study also analyzes the drivers and challenges affecting market growth and their influence on future market trends.

The market report also includes a SWOT analysis of the key players in the Patient-Derived Xenograft/PDX Model Market. This analysis provides an understanding of the strengths, weaknesses, opportunities, and threats of each company, which can be used to develop effective business strategies. Additionally, the report provides insights into the latest developments, new product launches, and partnerships of the key players in the market.

Segments Covered In the Patient-Derived Xenograft/PDX Model Market:
By Model Type (Athymic Nude Mice, Severely Compromised Immune Deficient (SCID) Mice, NOD-SCID Mice, and Recombination-Activating Gene 2 (Rag2)-Knockout Mice), By Cancer Type (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Gastric Cancer, Pancreatic Cancer, Pediatric Cancer, and Other Cancers), By Application (Pre Clinical Drug Development, Precision Medicine, Basic Cancer Research, Biomarker Analysis, Immunotherapy, and Others), By End Users (Pharmaceutical And Biotechnology Industries, Contract Research Organizations (CROs), Academic and Research Institutions and Others)

Key Players:
JSR Corporation
WuXi AppTec
GemPharmatech
Crown Bioscience
Champions Oncology, Inc.
The Jackson Laboratory
Cypre, Inc
Gustave Roussy
Oncodesign
Charles River Laboratories
Hera Biolabs
EPO Berlin-Buch
Envigo
Xentech
Urolead
Urosphere
Explora BioLabs

Table of Contents

154 Pages
1. Executive Summary
2. Patient-Derived Xenograft/PDX Model Market Introduction
3. Patient-Derived Xenograft/PDX Model Market Dynamics
4. Patient-Derived Xenograft/PDX Model Market Segmentation Analysis, 2020 - 2024 and Forecast 2025 – 2031
5. Competition Landscape
6. Research Methodology
7. Appendix and Abbreviations
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.